Medical Specialty >> Pharmacy
Study Affirms What Many Know: Antidepressants May Lead to Weight Gain
9:00 AM CDT.
By Steven ReinbergHealthDay Reporter Read article
- New Guidelines Mean 1 in 3 Adults May Need Blood Pressure Meds
- Treatment for Teething Pain Poses Serious Health Threat: FDA
- A Pill to Protect You From the Sun? Don’t Believe It, FDA Says
- Overdoses on ADHD Drugs May Be Rising
JOURNAL UPDATE
Rising Fatal Drug Overdoses Linked to Years of Life Lost
12:00 PM CDT. Growth in fatal overdoses linked to increased mortality, years of life lost for non-Hispanic whites- Global Variation in Personal Health Care Access and Quality
- Burosumab May Benefit Children With X-Linked Hypophosphatemia
- Delay of Lactate Draws in Sepsis Ups Risk of In-Hospital Death
MONTHLY JOURNAL SUMMARY
April 2018 Briefing - Pharmacy
May 01, 2018. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
Ted Lain, MD.
Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…
Bevacizumab for breast cancer: FDA grants a stay of execution
Dr. Alberto De la Guerra.
The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
MEDICAL FOCUS
DISCUSSION
RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
By MrRobinGreat articles. learnt a lot from it.
